KPIs & Operating Metrics(New)
Breakdown Of AssetsContractual ObligationCost Of RevenueCustomer Additions AnnualCustomers Count AnnualDeferred RevenueEmployee StatisticsGross Margin %Gross ProfitIncome (Loss) Before Income Taxes By RegionLong Lived AssetsNon Gaap ProfitabilityNon Gaap Profitability %Non Gaap Profitability AnnualNo. Of Genes ShippedNo. Of Genes Shipped AnnualNo. Of Orders TotalNo. Of Orders Total AnnualNo. Of ShipmentsOpex As A % Of Total Revenue %OPEX SegregationOrder BreakdownProperty And Equipment, Net BreakdownRevenue By GeographyRevenue By Geography %Revenue By Geography AnnualRevenue By Geography Annual %Revenue By IndustryRevenue By Industry %Revenue By Industry AnnualRevenue By Industry Annual %Revenue By ProductRevenue By Product %Revenue By Product AnnualRevenue By Product Annual %Revenue Mix From Repeat Customers %Shipped ProductsValue Of Orders
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Twist Bioscience (TWST) Gross Profit: 2018-2025

Historic Gross Profit for Twist Bioscience (TWST) over the last 8 years, with Sep 2025 value amounting to $50.8 million.

  • Twist Bioscience's Gross Profit rose 32.97% to $50.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $191.0 million, marking a year-over-year increase of 43.24%. This contributed to the annual value of $191.0 million for FY2025, which is 43.23% up from last year.
  • Per Twist Bioscience's latest filing, its Gross Profit stood at $50.8 million for Q3 2025, which was down 0.90% from $51.3 million recorded in Q2 2025.
  • Twist Bioscience's 5-year Gross Profit high stood at $51.3 million for Q2 2025, and its period low was $12.2 million during Q1 2021.
  • Moreover, its 3-year median value for Gross Profit was $35.3 million (2024), whereas its average is $35.4 million.
  • In the last 5 years, Twist Bioscience's Gross Profit spiked by 197.47% in 2021 and then fell by 12.90% in 2023.
  • Quarterly analysis of 5 years shows Twist Bioscience's Gross Profit stood at $15.0 million in 2021, then soared by 65.76% to $24.8 million in 2022, then increased by 16.78% to $29.0 million in 2023, then skyrocketed by 47.92% to $42.8 million in 2024, then surged by 32.97% to $50.8 million in 2025.
  • Its last three reported values are $50.8 million in Q3 2025, $51.3 million for Q2 2025, and $46.0 million during Q1 2025.